Target intelligence / Profile preview

Vertebral endplate (VEP)

Target
VEP
Molecular classification
Other
01

Overview

The vertebral endplate is a complex anatomical interface consisting of a cartilaginous layer and a subchondral bone layer that separates the vertebral body from the intervertebral disc (Source: StatPearls, NBK441915). Its primary biological function is to act as a semi-permeable barrier that facilitates the transport of essential nutrients like glucose and oxygen to the disc cells while allowing metabolic waste to exit (Source: PubMed, PMID: 15507787). Additionally, it plays a vital role in mechanical load distribution, protecting the disc from excessive pressure and maintaining spinal stability (Source: NIH, PMC3621213). In disease states such as intervertebral disc degeneration (IDD), the endplate often undergoes calcification or structural damage, which impairs nutrient flow and leads to disc dehydration and cell death (Source: PubMed, PMID: 23459133). Inflammatory changes within this environment, known as Modic changes, are strongly correlated with chronic low back pain and accelerated spinal aging (Source: PubMed, PMID: 18287995). Although not a single molecular target, the cellular environment of the endplate—including osteoblasts and chondrocytes—is targeted by bone-active drugs like bisphosphonates and growth factors to improve disc health (Source: PubMed, PMID: 27117192). Therapeutic interventions aim to maintain the porosity of the endplate and suppress local inflammation to halt the progression of degenerative spinal diseases (Source: PubMed, PMID: 30321454).

Other names
Cartilaginous endplateBony endplateVertebral body-disc interfaceCEPBEPHost bone cellular environment at vertebral endplates
02

Mechanism of action

Modulation of bone turnover and maintenance of endplate permeability to ensure nutrient supply to the intervertebral disc.

03

Biological functions

Nutrient transportMechanical load distributionBone remodelingCell signaling
04

Disease associations

Intervertebral disc degenerationLow back painModic changesOsteoporosisSpondylosis
05

Safety considerations

Avascularity limiting drug deliveryRisk of heterotopic ossificationSystemic side effects of bone-modifying agentsSurgical accessibility challenges
06

Interacting drugs

Zoledronic acid

3 more in the full profile.

07

Biomarkers

Modic changesC-terminal telopeptide (CTX)Procollagen type I N-terminal propeptide (P1NP)Interleukin-6

Beyond the preview

Go deeper on Vertebral endplate (VEP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vertebral endplate (VEP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call